ETHNIC DISTRIBUTION OF SLOW ACETYLATOR MUTATIONS IN THE POLYMORPHIC N-ACETYLTRANSFERASE (NAT2) GENE

被引:159
|
作者
LIN, HJ [1 ]
HAN, CY [1 ]
LIN, BK [1 ]
HARDY, S [1 ]
机构
[1] UNIV CALIF LOS ANGELES,SCH MED,DEPT SURG,TISSUE TYPING LAB,LOS ANGELES,CA 90024
来源
PHARMACOGENETICS | 1994年 / 4卷 / 03期
关键词
D O I
10.1097/00008571-199406000-00003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The acetylation polymorphism may affect rates of activation or detoxification of common carcinogens, thereby influencing cancer risk. Our aim was to define the ethnic distribution of the major slow acetylator mutations in the polymorphic N-acetyltransferase gene, in order to provide background data for epidemiological studies. Our results contain new analyses on 803 individuals, including 365 new specimens and 438 specimens that had been partly characterized in an earlier study. Tests were done to establish the specificity and reproducibility (98%) of our PCR assays. The recognized slow acetylator mutations, 191A, 481T, 590A, and 857A (which correspond to alleles M4 and M4b; M1 and r(3); M2/r(2); and M3 and S3, respectively), accounted for nearly all slow acetylator alleles among blacks, whites, Asian Indians, Hispanics, Koreans, Japanese, Hong Kong Chinese, Taiwanese, Filipinos and Samoans. The ethnic distribution supports an interpretation that the acetylation polymorphism existed before Paleolithic splitting of human populations from Africa. We identified two additional NAT2 mutations, suggesting that other rare alleles are likely to be found.
引用
收藏
页码:125 / 134
页数:10
相关论文
共 50 条
  • [1] POLYMORPHIC ARYLAMINE N-ACETYLTRANSFERASE ENCODING GENE (NAT2) FROM HOMOZYGOUS RAPID AND SLOW ACETYLATOR CONGENIC SYRIAN-HAMSTERS
    FERGUSON, RJ
    DOLL, MA
    BAUMSTARK, BR
    HEIN, DW
    GENE, 1994, 140 (02) : 247 - 249
  • [2] Polymorphic N-acetyltransferase (NAT2) genotyping of Emiratis
    Woolhouse, NM
    Qureshi, MM
    Bastaki, SMA
    Patel, M
    Abdulrazzaq, Y
    Bayoumi, RAL
    PHARMACOGENETICS, 1997, 7 (01): : 73 - 82
  • [3] Verified predominance of slow acetylator phenotype N-acetyltransferase 2 (NAT2) in a Hmong population residing in Minnesota
    Straka, Robert J.
    Burkhardt, R. Todd
    Lang, Nicholas P.
    Vang, Ter
    Hadsall, Kelly Z.
    Tsai, Michael Y.
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2006, 27 (06) : 299 - 304
  • [4] Arylamine N-acetyltransferase (NAT2) gene mutations in children with allergic diseases
    Zielinska, E
    Niewiarowski, W
    Bodalski, J
    Stanczyk, A
    Bolanowski, W
    Rebowski, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (06) : 635 - 642
  • [5] The association of polymorphic N-acetyltransferase (NAT2) with breast cancer risk
    Ambrosone, CB
    Freudenheim, JL
    Marshall, JR
    Graham, S
    Vena, JE
    Brasure, JR
    Michalek, AM
    Laughlin, R
    Nemoto, T
    Shields, PG
    CANCER PREVENTION: FROM THE LABORATORY TO THE CLINIC: IMPLICATIONS OF GENETIC, MOLECULAR, AND PREVENTIVE RESEARCH, 1995, 768 : 250 - 252
  • [6] Localization of polymorphic N-acetyltransferase (NAT2) in tissues of inbred mice
    Stanley, LA
    Mills, IG
    Sim, E
    PHARMACOGENETICS, 1997, 7 (02): : 121 - 130
  • [7] Prostate expression of N-acetyltransferase 1 (NAT1) and 2 (NAT2) in rapid and slow acetylator congenic Syrian hamster
    Hein, DW
    Doll, MA
    Xiao, GH
    Feng, Y
    PHARMACOGENETICS, 2003, 13 (03): : 159 - 167
  • [8] Analysis of N-acetyltransferase (NAT2) in three ethnic groups in Tunisia
    Attitallah, S
    Bechtel, YC
    Belkahia, C
    Bechtel, PR
    THERAPIE, 2000, 55 (03): : 361 - 369
  • [9] A new mutation (CT)-T-759 the polymorphic N-acetyltransferase (NAT2) gene
    Woolhouse, HM
    Qureshi, RM
    Bayoumi, RAL
    PHARMACOGENETICS, 1997, 7 (01): : 83 - 84
  • [10] Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populations
    Delomenie, C
    Sica, L
    Grant, DM
    Krishnamoorthy, R
    Dupret, JM
    PHARMACOGENETICS, 1996, 6 (02): : 177 - 185